S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Home
Investing
Stocks
Italy
BIT
Societe Generale Effekten (SCO2S3)
Societe Generale Effekten (SCO2S3) News

Societe Generale Effekten (SCO2S3)

0.18

0.0025

(1.41%)

Closed June 06 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

0 articles were found

Just give me $1.50

Just give me $1.50 4 minutes ago

This is your DAILY reminder to prepare your MIKAH questions for the upcoming MIKAH conference call.

Our goal on this board is to submit at least 100 QUESTIONS in total regarding The Mikah Scam.

June 15: 10-K filed after hours
June 16: Mikah conference call

DrivenByPain

DrivenByPain 5 minutes ago

Wrong ! No R/S Watch For Independent Director To Be Added 🤑SHTX🤑

It looks like we’ll have an update on the shareholder dividend VERY soon, along with additional acquisition and partnership developments currently in progress.

We also expect to begin addin

stoxjock

stoxjock 11 minutes ago

I really hope the "L1" Tranche pf RKT Shares are going to be utilized and that hopefully is to buy some Assets of WaMu and we get those shares by July 2nd week. Fingers Crossed!

GLTU & GLTA WaMu Escrow-Holders!

stoxjock

stoxjock 15 minutes ago

Ron,
Are the RE going into the WFC Trusts or US Bank's ones or both?
TIA & GLTU!

jondoeuk

jondoeuk 17 minutes ago

OT: 'A PRINTed GLA medicine that addresses the multi-organ impact of Fabry and deliver multi-year durability without the challenges of frequent dosing or viral vector-based delivery would be transformative for patients.' https://www.globenewswire.com/news-release/2026/05/12/3292599/0/en/addition-the

stoxjock

stoxjock 17 minutes ago

Husshh. Shhh.. Let Not the Word out Yet! Let us first get our WaMu 'Buckets' so that we Load up More of FnF...Lol!

1manband

1manband 18 minutes ago

If anyone is interested in a Whistleblower award for stock fraud, the SEC's program is a very high bar. Besides only paying once a monetary penalty is received by the Commission, the program also requires a long application process and any payments may come years after the tip is first given.

ScottishTexan

ScottishTexan 19 minutes ago

Search $vgls on X

getmoreshares

getmoreshares 20 minutes ago

lots of clown BS-- over 3/4 of the weekend posts-- Glad most of us do not waste our time reading them

skitahoe

skitahoe 23 minutes ago

The type of trial you're suggesting will never happen again, at least not with the DCVax's IMHO. The FDA and others are recognizing the benefits of treating all in a trial and letting the results go against the existing data for the disease in question. I believe that few trials in the future agai

Ridetherocket

Ridetherocket 27 minutes ago

Hold on , I'm obviously not as smart as you guys when it comes to this, BUT if it does an IPO all I will get is 1 share for every 23 I have now? So say I have 23,000 now, that becomes only 1000 after Ipo. Unless you have a million shares why in the world have I been holding on fnma for last six mt

Sammy boy

Sammy boy 30 minutes ago

Then we have Bill Pulte, I wish I could invest in these companies when the stock was trading near $13. Stock dips below $7 and the sleaze bag says nothing, tells you a lot about his character, nice guy!

gfp927z

gfp927z 31 minutes ago

Elton John -

https://youtu.be/8K5ecDiuQEE?list=RD8K5ecDiuQEE

---

delerious1

delerious1 33 minutes ago

"...it's an acronym." No it isn't.....er, an acronym....

DewDiligence

DewDiligence 40 minutes ago

Lilly also reported cases of dysesthesia, an abnormal sensation such as tingling or burning… IMO, this could turn out to be a pretty big impediment to commercial uptake (assuming regulatory approval). The dysesthesia issue was discussed on this board when LLY announced the topline results two weeks

meirluc

meirluc 41 minutes ago

Doc, if Flaskworks is not happening, why on earth is NWBO working to update the electrical infrastructure of the Grade C suite and complete the buildout of that suite?

As for whether Flaskworks is done or on the way is a question to be asked after that C suite work has been completed

GoodGuyBill

GoodGuyBill 44 minutes ago

Gary, normally I’d agree with you — in most cases, guys like Griffin write a inconsequential check, shrug it off, and the story ends. But the scale and duration of the misconduct here is so large, so well-documented, and so interconnected across multiple companies since 2017, that this isn’t just an

TightCoil

TightCoil 44 minutes ago

i'm on your side, with ya all the way,
i been tellin' 'em that for years, but no
one ever listens...and the PPS keeps goin' up.
keep trying, keep fightin' - we need you to be our leader

Longstrongsilver

Longstrongsilver 46 minutes ago

Yeah! Those shares are as restricted as Josh is. Locked up tight!

Scope08

Scope08 51 minutes ago

Thanks for doing the legwork on this Carl. For future reference. I’m in agreement on the no buy out stance.

Porch Honkey

Porch Honkey 52 minutes ago

They barely Hanging on, cash is running out, good luck getting out.

berta

berta 54 minutes ago

Longs Trust in the ongoing process I believe.
JMHO..

JD400

JD400 56 minutes ago

LIVE | Trump Administration Releases New Declassified UFO Files, Shocking Alien Evidence Testimony

Streamed live 10 hours ago #ufobombshell #usnewslive #ufotestimony

Trump Administration Releases New Declassified UFO Files LIVE: Shocking Alien Evidence Testimony

EddytheEagle

EddytheEagle 56 minutes ago

You are foolish to argue the effectiveness of dcvax combined with other therapeutics until it is proven in a well designed, randomized, double blind, placebo controlled clinical trial. All you have is a hypothesis. And you will never get MAA approval when all you have is a hypothesis.

Societe Generale Effekten

ClearWater Paper

OMX Copenhagen Industria...

Almonty Industries

Supersonic Imagine

Gas Oil Micro Securities

Gooroo Ventures

IA Clarington Loomis Glo...

HDAX Price Monthly Hedge...

Premier American Uranium

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.